Blog - Page 3001 of 5588

WednesdayJan 09, 2013 7:17 am

BIOLASE, Inc. (BIOL) Sells Last of WaterLase MD Turbo Laser Systems Repurchased from Schein

Leading global dental laser manufacturer and distributor BIOLASE announced that it has sold the last of 159 WaterLase MD Turbo laser systems the company repurchased from Henry Schein earlier this year. BIOLASE originally intended to use a portion of the purchased Schein inventory for parts to service its large installed base of MD Turbo laser systems. Due to high demand for the equipment, however, the company ultimately elected to sell all of the repurchased laser systems. Under a February 2012 agreement, BIOLASE repurchased the units from Schein at a very advantageous price, selling them throughout the last three quarters at…

TuesdayJan 08, 2013 2:23 pm

ZBB Energy Corp. (ZBB) Secures Order for Grid Independent ZBB EnerSystem with University of Technology Sydney

ZBB Energy, the developer of cutting-edge electrical power management platform architectures that fit the growing global need for distributed renewable energy, energy efficiency, power quality, and ultimately grid modernization, reported today that the company has landed an order for one of their Grid Independent ZBB EnerSystems™ (with ZBB EnerStore™ Zinc Bromide flow batteries), that is destined for a Microgrid Energy Management System at the University of Technology, Sydney (UTS). The ZBB microgrid solution will not only serve as a permanent power source in the Broadway Building on the UTS campus, but also as a demo installation and learning tool. In…

TuesdayJan 08, 2013 2:22 pm

Advanced Cell Technology (ACTC) Reports Milestone Achievement in Phase I/II Embryonic Stem Cell Clinical Trials

Investigators in Advanced Cell Technology’s phase I/II clinical trials for Stargardt’s macular dystrophy (SMD) and dry age-related macular degeneration (dry AMD) report that they have observed evidence of engraftment of the transplanted human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells as well as visual acuity gain in patients treated throughout the trial’s duration. The company has reached the halfway point in all three of its ongoing trials, stopping to assess the data and activity of the transplanted RPE cells. These most recent findings mark the first time the company has achieved engraftment and persistence in AMD, and is…

TuesdayJan 08, 2013 10:35 am

Genius Brands International, Inc. (GNUS) Continues to Innovate in Musical Education Products for Children

Genius Brands International has hit a real sweet spot in the music-based “edutainment” space with their award-winning Baby Genius® line of products, which feature engaging songs and fun characters that have struck a resounding chord with the infant to young child segment, as well as parents. The array of videos, books, and other merchandise produced by the company is distributed at wholesale to retail stores and outlet, as well as direct-to-consumer through “deal for a day” sites and the company’s own web portals. The company is seeing increased traction in target markets going into 2013, with a recent independent study…

TuesdayJan 08, 2013 10:34 am

QualityStocks Keeps Investors Abreast of Small-cap Market’s Latest and Greatest

There’s a barrage of financial information available at any given moment – while it initially sounds great, investors need a quick, clear-cut method to dig through the madness to find their next great investment opportunity. QualityStocks keeps investors up-to-date on everything related to the small-cap and micro-cap markets by offering several ways to filter through the information to easily find the material needed. The QualityStocks Blog is updated daily; investors can read about leading players in the small-cap and micro-cap markets and discover emerging companies flying under the radar along the way. We’re not just committed to the highlighting rising…

TuesdayJan 08, 2013 10:33 am

TNI BioTech, Inc. (TNIB) Secures the Exclusive Rights to Low Dose Naltrexone and Other Opioid Antagonists

Earlier today, TNI BioTech announced that it has entered into an agreement to acquire patent rights to a novel late-stage drug, trademarked “LDN,” for the treatment of Pediatric Crohn’s Disease. The patent acquired covers methods and formulations for treatment of the inflammatory and ulcerative diseases of the bowel, using naltrexone in low dose as an opioid antagonist. Endogenous opioids and opioid antagonists have been shown to play a role in stimulating and rebalancing the immune system and the healing and repair of tissues. As part of the agreement, TNI BioTech has obtained the right to apply to the Food and…

TuesdayJan 08, 2013 7:21 am

Pixelworks, Inc. (PXLW) Latest Video Processors to Debut in Ultra-High Definition TVs at CES

Innovative video and display processing technology pioneer Pixelworks announced yesterday that its latest MotionEngine video display processors will debut in 4Kx2K Ultra High Definition models from various Tier-one manufacturers at the Consumer Electronics Show this month. Establishing the new standard for immersive viewing, these new flat panel televisions deliver truly outstanding picture quality with 8 million pixels per frame, amounting to four times the resolution (3840 x 2160) of current full HD TVs. Due its fine pixel pitch, which creates a new level of realism and fidelity, Pixelworks’ latest video display processors are the ideal engine for driving higher resolutions…

TuesdayJan 08, 2013 7:19 am

Additional U.S. Government Facilities Select Viscount Systems, Inc. (VSYS) Freedom Security Software

Viscount Systems, a leading-edge supplier of security systems and software, this morning announced that its Freedom access control system has been installed at U.S. Federal Government facilities in two additional states. The systems include both Freedom Encryption bridge technology as well as Viscount’s new Freedom security user and card enrollment platform. Due to security precautions, the nature of the facilities and agency involved were not identified. “We continue to make progress in making Freedom the new defacto standard for securing Federal Government facilities,” commented Stephen Pineau, president and CEO.” Following successful pilot projects that demonstrated our ability to save agencies…

TuesdayJan 08, 2013 7:19 am

Dot Hill Systems Corp. (HILL) Protects Ability to Maximize Performance of Real-Time Tiered Storage

Dot Hill Systems, a leading provider of SAN storage solutions, announced that it has patented a new method for maximizing performance in its AssuredSAN(TM) Pro 5000 Series, the company’s real-time tiered storage solution. Dot Hill’s AssuredSAN Pro 5000 Series provides a real-time autonomic process to manage both “hot” and “cold” data, delivering storage performance when it’s most needed. The AssuredSAN(TM) Pro 5000 Series leverages this autonomic process to reduce waiting time for data searches. Traditional systems utilizing spinning disks can suffer from latency when a majority of data is concentrated on one drive. By removing the process of request queuing,…

MondayJan 07, 2013 2:26 pm

BrainStorm Cell Therapeutics, Inc. (BCLI) Receives Regulatory Nod for Phase IIa Study

The Israeli Ministry of Health has fast-tracked BrainStorm Cell Therapeutics’ current phase I/II ALS (Lou Gehrig’s disease) safety trial to a phase IIa dose-escalating trial designed to evaluate the safety and preliminary efficacy of the company’s NurOwn stem cell therapy candidate. The acceleration drastically expedites the company’s clinical development program and allows for its immediate launch at the Hadassah Medical Center in Jerusalem. “Acceleration to phase IIa will save us critical time, enabling us to proceed much more quickly with achieving our goal of developing an effective treatment for ALS,” Dr. Adrian Harel, BrainStorm’s CEO stated in the press release.…

Site Search

Company Search